← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
Carl Lindgren
Annan medlem i bolagets administrations-, lednings- eller kontrollorgan | Styrelseordförande
Profile key: se|carl lindgren
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 2
- Purchases · 24M
- 6
- Average purchase
- SEK 366,312
- Gross purchase value
- SEK 2,197,871
- Last purchase
- 2026-03-05
- Completed 20D events
- 6.0
- Outcome status
- PASS
Latest company: Iconovo AB
Companies: EQL Pharma AB | Iconovo AB
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 6Developing | 100.0% (6/6) | 50.0% (3/6) | -1.9% | +3.8% | -4.9% |
| 20D | 6Developing | 100.0% (6/6) | 50.0% (3/6) | +2.1% | +5.1% | -19.4% |
| 60D | 6Developing | 100.0% (6/6) | 50.0% (3/6) | +0.7% | +9.1% | -23.5% |
| 120D | 6Developing | 100.0% (6/6) | 16.7% (1/6) | -8.6% | -25.7% | -79.8% |
Research patterns
- First purchase in 12M
- 1/3
- Large purchase ≥ €100k
- 0/6
- Cluster buying · 15D
- 5/6
- Buying the dip · ≥20% below prior 52W high
- 5/5
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.